Back to Authors

Wijngaard, Peter L J

Mayo Clinic

From the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.); the Department of Cardiology, Mayo Clinic, Rochester, MN (R.S.W.); the Medicines Company, Zurich, Switze

Citations 1

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

New England Journal of Medicine | March 18, 2020 | Volume: 382 | Issue: 16 | Pages: 1507-1519

10.1056/nejmoa1912387 | PMID 32187462